Meet the inspiring mother-daughter duo starting their medical careers together

  • 📰 HealthyWomen
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 68%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Dr. Cynthia Kudji Sylvester and Dr. Jasmine Kudj, a mother-daughter duo, started their residencies together in the same hospital system, LSU Health.

, only about 5%, or 45,534 of physicians surveyed identified as black or African American. Kudji said, “It's honestly not very common. Like 2% of physicians are African American women. Even at the hospital that I'm going to start working at, there's only one African American female surgeon out of probably about 50.

“It's so important because when I was coming up, I remember watching 'The Cosby Show' or 'A Different World,' and we would all run to the television in college when that show would come on because you didn't have that. It was the first time you saw an African American doctor, African American attorney and a family and you saw that image before you," Kudji Sylvester said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 29. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Merck's Keytruda doesn't meet goals in bladder cancer studyMerck Inc. said late Tuesday that its drug Keytruda did not reach its goals in a late-stage clinical study for the treatment of bladder cancer. The drug maker said bladder cancer patients given Keytruda in a Phase 3 clinical study did not show a statistically significant improvement in overall survival or progression-free survival compared with patients given standard chemotherapy. Keytruda is already approved to treat several other types of cancer. In 2019, Merck reported Keytruda sales made up $11.08 billion of its $46.84 billion in sales. Merck shares rose 0.3% after hours, following a 0.7% decline to close the regular session at $82.26.
Source: MarketWatch - 🏆 3. / 97 Read more »